Skip To The Main Content

PDA Webinar: Regulatory Challenges, Perspectives, and Convergence to Progress ATMPs

Jun 30, 2020
Eastern Standard Time | Online
  • Virtual
  • Conference
  • Online


We’re proud to welcome Peter W. Marks, MD, PhD, Director, CBER, U.S. FDA, who is joining us for this final webinar in 2020 PDA Advanced Therapy Medicinal Products Month Webinar Series!

As more and more companies are transitioning into cell and gene manufacturing, it is imperative that regulatory requirements allow for an acceptable risk-based approach that can be applied across manufacturing sites.

This webinar will highlight global regulatory challenges, current regulatory thinking, and efforts that are being proposed and/or undertaken to promote convergence in global regulatory approaches for cell and gene therapy manufacturing.

In addition to the presentation by Dr. Marks, we will be hearing an industry perspective on lessons learned from an RMAT designation request.

Following the presentations, get your questions answered during a live 30-minute Q&A session with the speakers.

This webinar is presented as part of the 2020 PDA Advanced Therapy Medicinal Products Month.


  • 11:00 a.m. – 11:30 a.m.
    Moving Toward Global Regulatory Convergence for Advanced Therapy Medicinal Products
    Peter W. Marks, MD, PhD, Director, CBER, U.S. FDA

    11:30 a.m. – 12:00 p.m.
    Lesson Learned from an RMAT Designation Request
    Stephen P. Westover, Director of Regulatory Affairs, Cook Myosite Incorporated

    12:00 p.m. – 12:30 p.m.
    Q&A with Speakers

Highlighted Speakers

Peter W. Marks
Peter W. Marks
Stephen P. Westover
Stephen P. Westover
Cook MyoSite Incorporated

Registration Fees

Register Now
Registration Type Price
Member $200
Non-member $200
Gov't/Health Auth./Academic $200

Got a Question? We have answers

Contact Us
Become a Sponsor

Interested in becoming a sponsor? Learn about opportunities and benefits.

Request Information


Become an Exhibitor

Interested in becoming an exhibitor? Learn about opportunities and benefits.

Request Information

Attendee List Email Scam

Unfortunately, emails are circulating that offer to sell attendee lists for many of PDA’s conferences and events. These emails are sent by scammers.

Note: PDA does not sell its exhibitor or attendee lists, and no third-party is authorized to distribute or sell any lists related to our events. Statements claiming to offer our attendee lists are fraudulent. If you receive emails that propose to sell PDA conference attendee lists, do not engage with the sender and delete the message immediately.

Media Partners

Related Events


Program Inquiries
Exhibition Inquiries
Course Inquiries
Registration Customer Care

Tel: +1 (301) 656-5900 ext. 115
[email protected]

PDA Members Save Substantially